The MDM2 gene amplification database

J Momand, D Jung, S Wilczynski… - Nucleic acids …, 1998 - academic.oup.com
The p53 tumor suppressor gene is inactivated in human tumors by several distinct
mechanisms. The best characterized inactivation mechanisms are:(i) gene mutation;(ii) p53 …

The role of MDM2 amplification and overexpression in tumorigenesis

JD Oliner, AY Saiki… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Mouse double minute 2 (MDM2) is a critical negative regulator of the tumor suppressor p53,
playing a key role in controlling its transcriptional activity, protein stability, and nuclear …

Mdm2: keeping p53 under control

J Piette, H Neel, V Maréchal - Oncogene, 1997 - nature.com
The Mdm2 gene is overexpressed in several human tumors. The oncogenic potential of
Mdm2 is partially explained by the inhibition of the activity of the tumor suppressor protein …

A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations …

HC Hafkamp, EJM Speel, A Haesevoets… - … journal of cancer, 2003 - Wiley Online Library
Besides well‐known risk factors such as tobacco use and alcohol consumption, oncogenic
human papillomavirus (HPV) infection also has recently been suggested to promote head …

p53-dependent ceramide response to genotoxic stress.

GS Dbaibo, MY Pushkareva, RA Rachid… - The Journal of …, 1998 - Am Soc Clin Investig
Both p53 and ceramide have been implicated in the regulation of growth suppression. p53
has been proposed as the" guardian of the genome" and ceramide has been suggested as …

[PDF][PDF] Mdm-2:“big brother” of p53

J Momand, GP Zambetti - 1997 - escholarship.org
Loss of cell cycle control and increased genomic instability are characteristics of most tumor
cells. Activation of proto-oncogenes that promote cell growth in combination with the …

The p53 network in lung carcinogenesis

AI Robles, SP Linke, CC Harris - Oncogene, 2002 - nature.com
The p53 tumor suppressor gene lies at the crossroads of multiple cellular response
pathways that control a cell's fate in response to endogenous or exogenous stresses …

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

O Fortunato, M Boeri, M Moro, C Verri, M Mensah… - Cell death & …, 2014 - nature.com
Lung cancer represents the leading cause of cancer-related death in developed countries.
Despite the advances in diagnostic and therapeutic techniques, the 5-year survival rate …

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients …

M Higashiyama, K Kodama, H Yokouchi… - British journal of …, 1997 - nature.com
MDM2 is an oncoprotein that inhibits p53 tumour-suppressor protein. Amplification of the
MDM2 gene and overexpression of its protein have been observed in some human …

TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value

C Deben, V Deschoolmeester, F Lardon, C Rolfo… - Critical reviews in …, 2016 - Elsevier
The p53 pathway has been extensively studied for its role in carcinogenesis. Disruption of
the pathway occurs in more than half of all cancers, often leading to a worse prognosis for …